glp 1 drugs thyroid cancer GLP-1 agonist like Ozempic do not increase risk Ozempic: EU Sees No Evidence

Novo Nordisk and Eli Lilly bring their longtime rivalry to GLP-1 pills and prepare to make their pitch to seniors with Medicare.

Diabetes mellitus is a major risk factor for both cardiovascular and chronic kidney disease (CKD) while CKD is also associated with cardiovascular morbidity

Discover how these popular medications may impact your vein health, including their effects on varicose veins, chronic venous insufficiency, circulation, and blood clot

Evidence-based insights for patients and providers.

Glucagon-like peptide (GLP)-1 receptor agonists are the cornerstone in the treatment of hyperglycemia in many people suffering from type 2 diabetes (T2D)